Prefillable Polymer Syringes for Sensitive Active Ingredients

Polymer syringes

As diverse as the applications

The material used for the syringes is a high performance polymer called COP (Cyclic Olefin Polymer). It is suitable for use as primary packaging for sophisticated medications, especially for sensitive biologicals, biosimilars and biobetters, but also e.g. hyaluronic acid applications.

COP polymer syringes are distinguished by a high degree of break resistance and a glass-like transparency. COP releases no alkali ions, which means that the risk of a pH value shift is eliminated. Since the entire plastic syringe, including the insert-molded needle, is produced in a single step, the polymer syringes hence become free of tungsten and adhesives.

Production in the injection molding process ensures precise dimensions. The dead volume in the polymer syringe is also minimized, reducing overall waste of the costly drugs. The material enables a broad range of design options, which make it ideal for customer specific-requirements. The polymer syringes are also engineered for use in autoinjectors thanks to their robustness and  precision.

We also offer our customers an extensive portfolio of prefillable glass syringes that are adapted to the current requirements of the pharmaceutical industry and fulfill the requirements of modern filling systems.

Advantages prefillable COP polymer syringes
Prefillable Polymer Syringes for Sensitive Active Ingredients
To advantages
Gx RTF ClearJect needle syringes
Prefillable Polymer Syringes for Sensitive Active Ingredients
To RTF ClearJect
ClearJect luer lock syringes
Prefillable Polymer Syringes for Sensitive Active Ingredients
To ClearJect luer lock syringes
ClearJect luer cone syringes
Prefillable Polymer Syringes for Sensitive Active Ingredients
To ClearJect luer cone syringes
Accessoires
Accessoires - Gerresheimer
To accessoires

Contact us!

Steve Hourmezian
Sales USA

Phone: +1 678 951 3959
E-Mail: Steve Hourmezian

Bartosz Nowak
Sales Europe & Asia
Phone: +49 171 9248788
E-Mail: Bartosz Nowak